
Marshall Wace
27 portfolio companies · 5 on the map · $1.3B raised · 4 cities · mwam.com
Portfolio map
5 Marshall Wace portfolio companies on the map.
Portfolio companies

Amylyx Pharmaceuticals
Cambridge
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Pharmaceutical Manufacturing$623.5M
Human Interest
San Francisco
**The 401(k) for small and medium-sized businesses.** Human Interest is on a mission to ensure that people in all lines of work have access to retirement benefits. Nearly half of all working Americans are not saving enough for their future
FinTech$500MEst. 2015Hiring fast
TRM Labs
San Francisco
TRM Labs is a blockchain intelligence company helping financial institutions, crypto businesses, and government agencies detect and investigate crypto-related financial crime and fraud, addressing data engineering, data science, and threat
Blockchain$218.2MEst. 2018Hiring fast
ADARx Pharmaceuticals
San Diego
ADARx Pharmaceuticals, Inc., a San Diego-based clinical-stage biotechnology company, develops RNA-targeting platforms and oligonucleotide delivery technologies to inhibit, degrade, or edit disease-causing mRNA, pursuing programs across gene
BiotechnologyEst. 2019
Lycia Therapeutics
South San Francisco
Lycia is a Series B biotech company built on a platform developed by academic founder Professor Carolyn Bertozzi at Stanford, arising from Stanford research, with potential to deliver next-generation therapeutics for difficult-to-treat dise
BiotechnologySeries CEst. 2020
More portfolio companies
22 more Marshall Wace investments we track beyond the map.
ConsenSysBrooklyn · Series D
RippleSan Francisco · Venture
CircleNew York · Post-IPO Equity
Parse BiosciencesSeattle · Series C
VeraDermicsNew Haven · Series C
Forge BiologicsGrove City · Series B
FlywireBoston · Series F
AccelerantAtlanta · Private Equity
Asher BioSan Francisco · Series B
TipaltiFoster City · Series F
21.coZürich · Venture
Prognos HealthNew York · Venture
ACELYRINLos Angeles · Series C
International Airlines Group (IAG)Uxbridge · Post-IPO Equity
BlueWhale BioPhiladelphia · Seed
INBRACEIrvine · Series D
ExscientiaOxford · Series D
Sammaan CapitalMumbai · Post-IPO Equity
LukkaNew York · Series E
RezoluteLouisville · Post-IPO Equity
NeurogastrxWoburn · Series B
MindMedNew York · Post-IPO Equity
Portfolio map
5 Marshall Wace portfolio companies on the map.